基于R2*映射和临床生物标志物的影像组学列线图用于慢性乙型肝炎患者肝纤维化分期:单中心回顾性研究
本研究纳入慢性乙型肝炎患者,利用R2*映射提取影像组学特征并结合临床变量构建列线图,在测试队列中分期显著纤维化、进展性纤维化和肝硬化的AUC分别为0.738、0.879和0.952;列线图对进展性纤维化和肝硬化有临床获益,但对显著纤维化价值有限。
要点
- 基于R2*映射的影像组学列线图对分期进展性纤维化和肝硬化有较好价值。
- 层粘连蛋白和血小板是进展性纤维化的独立预测因子。
- 影像组学列线图难以区分显著纤维化。
核心结论
- 联合R2*映射Radscore、层粘连蛋白和血小板的影像组学列线图对进展性纤维化和肝硬化有分期价值,但对显著纤维化分期价值有限。
研究设计与样本
- 单中心回顾性研究;训练队列103例、验证队列48例(2020年1月至12月随机分组),测试队列58例(2021年1月至2月);采用R2*映射影像组学特征和临床变量构建列线图,以AUC评估性能。
诊断标准与关键数值
- 测试队列中,列线图分期显著纤维化、进展性纤维化和肝硬化的AUC分别为0.738(95%CI:0.604-0.872)、0.879(95%CI:0.779-0.98)和0.952(95%CI:0.878-1)。
临床应用与阅片要点
- 基于R2*映射的影像组学列线图可能有助于评估进展性纤维化和肝硬化;作者指出该列线图难以区分显著纤维化,可能源于慢性肝病复杂的病理微环境。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the value of R2* mapping-based radiomics nomograms in staging liver fibrosis in patients with chronic hepatitis B.
METHODS: Between January 2020 and December 2020, 151 patients with chronic hepatitis B were randomly divided into training (n = 103) and validation (n = 48) cohorts. From January to February 2021, 58 patients were included in a test cohort. Radiomics features were selected using the interclass correlation coefficient and least absolute shrinkage and selection operator method. Three radiomics nomograms, combining the radiomics score (Radscore) derived from R2* mapping and clinical variables, were used for staging significant and advanced fibrosis, and cirrhosis. Performance of the model was evaluated using the AUC. The utility and clinical benefits were evaluated using the continuous net reclassification index (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA).
RESULTS: The Radscore calculated by 12 radiomics features and independent factors (laminin and platelet) of advanced fibrosis were used to construct the radiomics nomograms. In the test cohort, the AUCs of the radiomics nomograms for staging significant fibrosis, advanced fibrosis, and cirrhosis were 0.738 (95% confidence interval [CI]: 0.604-0.872), 0.879 (95% CI: 0.779-0.98), and 0.952 (95% CI: 0.878-1), respectively. NRI, IDI, and DCA confirmed that radiomics nomograms demonstrated varying degrees of clinical benefit and improvement for advanced fibrosis and cirrhosis, but not for significant fibrosis.
CONCLUSIONS: Radiomics nomograms combined with R2* mapping-based Radscore, laminin, and platelet have value in staging advanced fibrosis and cirrhosis but limited value for staging significant fibrosis.
KEY POINTS: • Laminin and platelets were independent predictors of advanced fibrosis. • Radiomics analysis based on R2* mapping was beneficial for evaluating advanced fibrosis and cirrhosis. • It was difficult to distinguish significant fibrosis using a radiomics nomogram, which is possibly due to the complex pathological microenvironment of chronic liver diseases.
引用
- Zhang D, Cao Y, Sun Y, et al. Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study. Eur Radiol. 2022. PMID: 36149481. doi:10.1007/s00330-022-09137-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。